Form 4: Exact Sciences CFO Jeffrey Elliott Reports Stock Transactions
SEC Form 4 Filing
Chief Financial Officer of Exact Sciences, Jeffrey Elliott, reports the vesting of restricted stock units and subsequent sale of shares to cover withholding taxes.
Summary
- Jeffrey Elliott, CFO of Exact Sciences, reported transactions involving the company's common stock.
- On February 29, 2024, 5,291 shares were acquired upon the vesting of restricted stock units.
- On March 1, 2024, 2,412 shares were sold at $59.32 per share to cover withholding taxes related to the vesting of restricted stock units.
- Following these transactions, Elliott directly owns 10,933 shares of common stock and indirectly owns 1,585 shares held in a 401(k) plan.
- Elliott also holds 134,437 vested and unvested options and restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives at publicly traded companies. These transactions are often related to compensation packages that include stock options and restricted stock units.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they represent a small portion of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Restricted stock units vested, resulting in the acquisition of 5,291 shares. |
| 03/01/2024 | 2,412 shares were sold at $59.32 per share to cover withholding taxes. |
| 03/04/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.